BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

Posted in: Medical Condition News | Pharmaceutical News

Tags: Addiction, Analgesia, Anaphylactic Shock, Anxiety, Breast Milk, Breastfeeding, Cancer, Chronic Pain, Constipation, Diabetic Neuropathy, Diarrhea, Drug Delivery, Drugs, Fatigue, Headache, Heroin, Hypotension, Insomnia, Medicaid, Methadone, Morphine, Neuropathy, New Drug Application, Opioid Dependence, Opioids, Oxycodone, Pain, Pain Management, Sleep, therapeutics, Vomiting